Several aspects of collaboration, involving organoid- and zebrafish– guided drug discovery technologies with Johns Hopkins Hospital, Baltimore, MD, USA are projected. Thanks to Eric Raabe, from Oncology and Pathology Johns Hopkins for visiting and giving a reflective and concept lecture.
Funding was received to engage in manufecturing of stem cell homing peptides as part of the European nanomedicine initiative COST Action 17140 Nano2Clinic. Looking forward to deepen the collaboration with Tambet Teesalo and his Lab of Cancer Biology in Tartu.
P53 is the housekeeper of genome stability and cell differentiation. M.Sc. C. Uhlmann overexpresses TP53 hotspot isoform in pluripotent hiPSC to create novel in vitro study tools.